DK5089D0 - 2-substituerede adenosinderivater - Google Patents

2-substituerede adenosinderivater

Info

Publication number
DK5089D0
DK5089D0 DK005089A DK5089A DK5089D0 DK 5089 D0 DK5089 D0 DK 5089D0 DK 005089 A DK005089 A DK 005089A DK 5089 A DK5089 A DK 5089A DK 5089 D0 DK5089 D0 DK 5089D0
Authority
DK
Denmark
Prior art keywords
substituted
adenosin
derivatives
adenosin derivatives
substituted adenosin
Prior art date
Application number
DK005089A
Other languages
English (en)
Other versions
DK5089A (da
Inventor
Alan J Hutchison
John E Francis
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK5089D0 publication Critical patent/DK5089D0/da
Publication of DK5089A publication Critical patent/DK5089A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/173Purine radicals with 2-deoxyribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK005089A 1988-01-07 1989-01-06 2-substituerede adenosinderivater DK5089A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14205588A 1988-01-07 1988-01-07
US07/193,968 US5034381A (en) 1988-01-07 1988-05-13 2-(substituted amino) adenosines as antihypertensives

Publications (2)

Publication Number Publication Date
DK5089D0 true DK5089D0 (da) 1989-01-06
DK5089A DK5089A (da) 1989-07-08

Family

ID=26839719

Family Applications (1)

Application Number Title Priority Date Filing Date
DK005089A DK5089A (da) 1988-01-07 1989-01-06 2-substituerede adenosinderivater

Country Status (17)

Country Link
US (1) US5034381A (da)
EP (1) EP0323807A3 (da)
JP (1) JPH01265100A (da)
KR (1) KR890011903A (da)
AU (1) AU618055B2 (da)
CA (1) CA1325209C (da)
DD (1) DD283402A5 (da)
DK (1) DK5089A (da)
FI (1) FI90430C (da)
HU (1) HU202550B (da)
IL (1) IL88877A0 (da)
MX (1) MX14446A (da)
NO (1) NO169843C (da)
NZ (1) NZ227542A (da)
PH (1) PH26672A (da)
PT (1) PT89392B (da)
ZA (1) ZA8984B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977144A (en) * 1988-08-02 1990-12-11 Ciba-Geigy Corporation Imidazo[4,5-b]pyridine derivatives as cardiovascular agents
AU3820989A (en) * 1988-08-02 1990-02-08 Ciba-Geigy Ag 7-amino-3-beta-d-ribofuranosyl-3h-imidazo(4,5-b) pyridin-5-amine derivatives
US5189027A (en) 1990-11-30 1993-02-23 Yamasa Shoyu Kabushiki Kaisha 2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases
US5206222A (en) * 1991-05-22 1993-04-27 Vanderbilt University Methods for the reduction of myocardial reperfusion injury
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
US5426101A (en) * 1992-09-30 1995-06-20 Merrell Dow Pharmaceuticals Inc. 2-substituted adenosines with A-2 receptor affinity
IL107101A0 (en) * 1992-09-30 1993-12-28 Merrell Dow Pharma 2-substituted adenosines with a-2 receptor affinity
WO1994023723A1 (en) * 1993-04-15 1994-10-27 New York University Adenosine receptor agonists for the promotion of wound healing
US5817641A (en) * 1994-07-21 1998-10-06 Thomas Jefferson University Treatment of enterotoxigenic diarrhea with 2-substituted adenosine derivatives
AU740770B2 (en) 1997-06-18 2001-11-15 Aderis Pharmaceuticals, Inc. Compositions and methods for preventing restenosis following revascularization procedures
US5972903A (en) * 1997-10-07 1999-10-26 Regents Of The University Of California Corporation Method for promoting angiogenesis using heparin and adenosine
AU9790998A (en) 1997-10-07 1999-04-27 Regents Of The University Of California Corporation Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine
RU2209210C2 (ru) * 1998-07-09 2003-07-27 Санкио Компани, Лимитед Производные капурамицина, обладающие антибактериальной активностью, содержащие их фармацевтические композиции, способ лечения инфекционных заболеваний, микроорганизм, способный вырабатывать вышеуказанные производные, и способ получения таких производных с помощью этого микроорганизма
WO2000063703A1 (en) 1999-04-16 2000-10-26 Schering Corporation Use of azetidinone compounds
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
US20050033044A1 (en) 2003-05-19 2005-02-10 Bristol-Myers Squibb Pharma Company Methods for preparing 2-alkynyladenosine derivatives
JP2008530229A (ja) 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
US20090136460A1 (en) * 2007-07-10 2009-05-28 Vanderbilt University Use of adenosine receptor ligands to promote cell adhesion in cell-based therapies
KR102313314B1 (ko) * 2013-10-23 2021-10-19 아카데미아 시니카 신경퇴행성 질환 및 통증의 예방 및 치료에 사용하기 위한 화합물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670265A1 (de) * 1967-08-25 1971-01-28 Boehringer Mannheim Gmbh 2-Amino-Adenosinderivate und Verfahren zu deren Herstellung
NL7203984A (da) * 1971-04-10 1972-10-12
US3917583A (en) * 1972-08-04 1975-11-04 Icn Pharmaceuticals 2-Substituted cyclic AMP derivatives
AR205247A1 (es) * 1973-02-07 1976-04-21 Icn Pharmaceuticals Procedimiento para preparar derivados de amp 2-substituidos
JPS5630355B2 (da) * 1974-01-21 1981-07-14
AU5118979A (en) * 1978-10-16 1980-04-24 Takeda Chemical Industries Ltd. 2,6-diaminoebularines
JPS55139399A (en) * 1979-04-12 1980-10-31 Asahi Chem Ind Co Ltd Novel adenosine derivative substituted in the 2-position
JPS56152437U (da) * 1980-04-14 1981-11-14
US4501735A (en) * 1983-12-05 1985-02-26 Warner-Lambert Company N6-(1- and 2-benzocycloalkyl) adenosines
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
EP0305643B1 (en) * 1984-04-18 1994-01-05 Whitby Research Incorporated N-6 thienyl substituted adenosine derivatives as cardiac vasodilators
US4594350A (en) * 1984-07-30 1986-06-10 Reagents Of University Of Minnesota (3-ethoxypropionate) esters of cyclaradine
US4791103A (en) * 1985-02-08 1988-12-13 Warner-Lambert Company 2,N6 -disubstituted adenosines, derivatives and methods of use
US4593019A (en) * 1984-10-26 1986-06-03 Warner-Lambert Company N6 -tricyclic adenosines
US4683223A (en) * 1985-09-09 1987-07-28 Warner-Lambert Company N6 -Benzopyrano-and benzothiopyrano adenosines and methods of use
US4600707A (en) * 1985-01-25 1986-07-15 Warner-Lambert Company Benzothien-3-yl adenosine; benzothien-3-yl adenosine, S-oxide; and benzothien-3-yl, S,S-dioxide adenosine compounds
US4755594A (en) * 1986-01-31 1988-07-05 Warner-Lambert Company N6 -substituted adenosines
US4843066A (en) * 1986-11-27 1989-06-27 Nippon Zoki Pharmaceutical Co., Ltd. Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient
PT86660B (pt) * 1987-02-04 1992-02-28 Ciba Geigy Ag Processo para a preparacao de derivados de adenosina-5'-carboxamida

Also Published As

Publication number Publication date
HU202550B (en) 1991-03-28
PT89392B (pt) 1993-09-30
CA1325209C (en) 1993-12-14
HUT48904A (en) 1989-07-28
PT89392A (pt) 1990-02-08
NO885821D0 (no) 1988-12-30
IL88877A0 (en) 1989-08-15
NO169843B (no) 1992-05-04
US5034381A (en) 1991-07-23
AU618055B2 (en) 1991-12-12
FI890028A (fi) 1989-07-08
NO169843C (no) 1992-08-12
DK5089A (da) 1989-07-08
AU2776789A (en) 1989-07-13
NO885821L (no) 1989-07-10
KR890011903A (ko) 1989-08-23
JPH01265100A (ja) 1989-10-23
EP0323807A2 (en) 1989-07-12
FI90430C (fi) 1994-02-10
FI90430B (fi) 1993-10-29
MX14446A (es) 1994-01-31
PH26672A (en) 1992-09-15
DD283402A5 (de) 1990-10-10
NZ227542A (en) 1992-03-26
EP0323807A3 (en) 1990-06-20
ZA8984B (en) 1989-08-30
FI890028A0 (fi) 1989-01-04

Similar Documents

Publication Publication Date Title
TR26815A (tr) Azolilmetil-sikropil türevleri
DE68925405D1 (de) Carbostyril-Derivate
KR900700424A (ko) 디플루오로벤젠 유도체
DE68925161D1 (de) Alkylavermectin-Derivate
DK5089D0 (da) 2-substituerede adenosinderivater
DE68927948D1 (de) Trehalosderivate
DK391189A (da) Carbostyrilderivater
DK19789D0 (da) Dehydrocholcalciferolderivater
TR24894A (tr) N-FENILPIRAZOL TüREVLERI
DK507188D0 (da) Cholecalciferolderivater
DE68927657D1 (de) Butynylaminderivate
DK378088A (da) Alkenderivater
DK486089D0 (da) Pyranobenzoxadiazolderivater
DK49688A (da) Propiolophenonderivater
DK81989D0 (da) Substituerede quinolinderivater
DK82189D0 (da) Substituerede quinolinderivater
DE3824433A1 (de) Fluorcyclopropyl-derivate
DK160389A (da) Aryldionderivater
DK271088D0 (da) Tienopyridinderivater
DK339189A (da) Purinderivater
ATA155589A (de) Mitomycinphosphat-derivate
DK695788D0 (da) Naphtalenderivater
DE68927179D1 (de) Carbostyril-derivate
DK324489A (da) Substituerede azacyclohexylderivater
DK82089A (da) Substituerede quinolinderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment